The GI Cancer Institute saves lives by funding gastro-intestinal (GI) cancer clinical trial research in Australia. Gastro-Intestinal (GI) cancers include the oesophagus, stomach, liver, gallbladder, pancreas and bowel. GI Cancers are the most common form of cancer, directly affecting more than 24,000 Australians each year and claiming a devastating 33 lives a day. The research that we fund enables Australians with GI cancer to receive the best medical treatment. By conducting research in Australia, our cancer patients receive new treatments three to five years earlier than if the research was to take place overseas. Our clinical trials allow us to find better ways to treat GI cancers.